Among the Siglec family members, Siglec-15 is of particular interest in cancer immunity because of its substantial expression on the surface of macrophages and cancer cells, which is mutually exclusive to that of PD-L1, implicating that it may function as a crucial immune evasion mechanism in patients with negative PD-L1 expression. Here, CD274 is linked to cancer.